Literature DB >> 24118014

Pharmacological strategies for detoxification.

Alison M Diaper1, Fergus D Law, Jan K Melichar.   

Abstract

Detoxification refers to the safe discontinuation from a substance of dependence and is distinct from relapse prevention. Detoxification usually takes between a few days and a few weeks to complete, depending on the substance being misused, the severity of dependence and the support available to the user. Psychosocial therapies alongside pharmacological treatments are essential to improve outcome. The dependencies considered in this overview are detoxification from opioids (with methadone, buprenorphine, α2-adrenoceptor agonists and adjunct medications), alcohol (with benzodiazepines, anti-glutamatergics and γ-aminobutyric acid (GABA)-ergic drugs), stimulants and cannabis (with no clear recommended pharmacological treatments), benzodiazepines (with dose tapering) and nicotine (with nicotine replacement therapy, antidepressants and partial agonists). Evidence is limited by a lack of controlled trials robust enough for review bodies, and more research is required into optimal treatment doses and regimes, alone and in combination.
© 2013 The British Pharmacological Society.

Keywords:  alcohol; cannabis; cocaine; detoxification; nicotine; opioid

Mesh:

Year:  2014        PMID: 24118014      PMCID: PMC4014033          DOI: 10.1111/bcp.12245

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  116 in total

1.  Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.

Authors:  Luc Staner; Peter Boeijinga; Thierry Danel; Isabelle Gendre; Muriel Muzet; Frédéric Landron; Rémy Luthringer
Journal:  Alcohol Clin Exp Res       Date:  2006-09       Impact factor: 3.455

Review 2.  Current and emerging pharmacotherapies for treating tobacco dependence.

Authors:  Robert A Schnoll; Caryn Lerman
Journal:  Expert Opin Emerg Drugs       Date:  2006-09       Impact factor: 4.191

3.  Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

Authors:  Bertha K Madras; Zhihua Xie; Zhicheng Lin; Amy Jassen; Helen Panas; Laurie Lynch; Ryan Johnson; Eli Livni; Thomas J Spencer; Ali A Bonab; Gregory M Miller; Alan J Fischman
Journal:  J Pharmacol Exp Ther       Date:  2006-08-02       Impact factor: 4.030

4.  Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Authors:  Kirsten C Morley; Maree Teesson; Sophie C Reid; Claudia Sannibale; Clare Thomson; Nghi Phung; Martin Weltman; James R Bell; Kylie Richardson; Paul S Haber
Journal:  Addiction       Date:  2006-10       Impact factor: 6.526

Review 5.  Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe!

Authors:  C Harper
Journal:  Eur J Neurol       Date:  2006-10       Impact factor: 6.089

6.  Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.

Authors:  Alan J Budney; Ryan G Vandrey; John R Hughes; Brent A Moore; Betsy Bahrenburg
Journal:  Drug Alcohol Depend       Date:  2006-06-12       Impact factor: 4.492

7.  A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.

Authors:  Kyle M Kampman; Charles Dackis; Kevin G Lynch; Helen Pettinati; Carlos Tirado; Peter Gariti; Thorne Sparkman; Michal Atzram; Charles P O'Brien
Journal:  Drug Alcohol Depend       Date:  2006-05-11       Impact factor: 4.492

8.  Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.

Authors:  John W Davison; Marie L Sweeney; Kristen R Bush; Tania M Davis Correale; Donald A Calsyn; Joseph P Reoux; Kevin L Sloan; Daniel R Kivlahan
Journal:  J Addict Dis       Date:  2006

9.  Cocaine withdrawal symptoms predict medication response in cocaine users.

Authors:  Mehmet Sofuoglu; James Poling; Gerardo Gonzalez; Kishor Gonsai; Thomas Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2006       Impact factor: 3.829

Review 10.  Management of methamphetamine abuse and dependence.

Authors:  Walter Ling; Richard Rawson; Steve Shoptaw; Walter Ling
Journal:  Curr Psychiatry Rep       Date:  2006-10       Impact factor: 8.081

View more
  12 in total

1.  Drugs for addiction: a therapeutic area in need of a 'shot in the arm'.

Authors:  Andrea L Malizia; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 2.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

Review 3.  Treatment Strategies for the Opioid-Dependent Patient.

Authors:  Shweta Teckchandani; Meredith Barad
Journal:  Curr Pain Headache Rep       Date:  2017-09-20

Review 4.  Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.

Authors:  Jinhee Lee; Thomas F Kresina; Melinda Campopiano; Robert Lubran; H Westley Clark
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

5.  Sophora alopecuroides L. var. alopecuroides alleviates morphine withdrawal syndrome in mice: involvement of alkaloid fraction and matrine.

Authors:  Saeed Kianbakht; Fataneh Hashem Dabaghian
Journal:  Iran J Basic Med Sci       Date:  2016-10       Impact factor: 2.699

6.  Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.

Authors:  Marc Fishman; Carlos Tirado; Danesh Alam; Kristen Gullo; Thomas Clinch; Charles W Gorodetzky
Journal:  J Addict Med       Date:  2019 May/Jun       Impact factor: 3.702

Review 7.  The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies.

Authors:  Joseph K Nuamah; Farzan Sasangohar; Madhav Erraguntla; Ranjana K Mehta
Journal:  BMC Med Inform Decis Mak       Date:  2019-06-18       Impact factor: 2.796

Review 8.  Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation.

Authors:  Dimy Fluyau; Neelambika Revadigar; Brittany E Manobianco
Journal:  Ther Adv Psychopharmacol       Date:  2018-02-09

9.  Efficacy and Safety of Fentanyl in Combination with Midazolam in Children on Mechanical Ventilation.

Authors:  Bongjin Lee; June Dong Park; Yu Hyeon Choi; Young Joo Han; Dong In Suh
Journal:  J Korean Med Sci       Date:  2019-01-07       Impact factor: 2.153

Review 10.  Auricular neural stimulation as a new non-invasive treatment for opioid detoxification.

Authors:  Imran S Qureshi; Timir Datta-Chaudhuri; Kevin J Tracey; Valentin A Pavlov; Andrew C H Chen
Journal:  Bioelectron Med       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.